CDK9-IN-1 T10741
Specifications
| 1mg/5mg/10mg/25mg/50mg/100mg |
Bioactivity:
CDK9-IN-1 is a novel, selective CDK9 inhibitor for the treatment of HIV infection (IC50: 39 nM for CDK9/CycT1).
CAS nr:
1415559-43-1
Purity:
98%
Molecular Weight:
499,54
SMILES:
CC1=C(NS(C)(=O)=O)C=C(NC2=NC=NC(C3=CC=CC(N4C(C5=C(C=CC=C5)C4=O)=O)=C3)=C2)C=C1
Formula:
C26H21N5O4S
Pathway:
Cell Cycle/Checkpoint
Target:
CDK
